Abraxane and Alimta in Advanced Solid Tumors (UCDCC#185)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Celgene Corporation
Eli Lilly and Company
Information provided by (Responsible Party):
University of California, Davis
ClinicalTrials.gov Identifier:
NCT00470548
First received: May 3, 2007
Last updated: April 10, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)